Outpatient visits and antibiotic use due to higher valency pneumococcal vaccine serotypes.

Laura M KingKristin L AndrejkoSarah KabbaniSarah C RobinsonLauri A HicksAdam L CohenMiwako KobayashiJoseph A Lewnard

Published in: The Journal of infectious diseases (2024)

Compared with PCV15-additional serotypes, PCV20-additional serotypes account for >5 times the burden of visits and antibiotic prescriptions. Higher-valency PCVs, especially PCV20, may contribute to preventing pediatric pneumococcal respiratory infections and antibiotic use.

Keyphrases

risk factors
young adults